The Testosterone Trap: Understanding Hormone Health Before Starting Testosterone Replacement Therapy
The surge in testosterone replacement therapy (TRT) prescriptions tells a compelling story about modern men's health concerns. Between 2001 and 2011, prescriptions for TRT among men 40 years of age or older in the United States increased more than threefold (Baillargeon et al., 2013). Marketing campaigns promise increased energy, mental sharpness, muscle mass, and improved sexual function. These benefits are real for men with genuinely low testosterone levels. However, the decision to begin TRT requires careful consideration, comprehensive testing, and understanding of both the biochemistry involved and the potential long-term consequences. This article explores what every man should know before embarking on testosterone supplementation.
Summary:
How the body produces testosterone from DHEA through a complex enzymatic process
Why standard testosterone labs often fail to capture the complete picture
The critical difference between total testosterone and free testosterone
Why year-over-year lab data matters more than a single test result
The often-overlooked consequences of testosterone supplementation including effects on fertility, cardiovascular health, and hematocrit levels
How DHT conversion accelerates male pattern baldness in genetically susceptible men
Essential questions to ask your physician before starting TRT
How acupuncture supports natural hormone balance through cortisol regulation
The Biochemistry: From DHEA to Testosterone
Understanding testosterone production requires familiarity with the endocrine system's elegant complexity. Testosterone doesn't exist in isolation but rather as part of an interconnected hormonal cascade where multiple glands and tissues work together to maintain balance.
DHEA: The Precursor Hormone
Dehydroepiandrosterone, commonly known as DHEA, serves as one of the body's most abundant steroid hormones and acts as a crucial precursor to sex hormones including testosterone and estrogen. DHEA is produced primarily in the zona reticularis of the adrenal cortex under the control of adrenocorticotropic hormone, or ACTH, and by the gonads under the control of gonadotropin-releasing hormone. The body also produces DHEA in the brain (Hornsby, 1995).
Adrenal production of DHEA begins during puberty and peaks around 20 years old. At approximately age 25, serum DHEA begins to decline rapidly, so that by age 75, DHEA level is approximately 80% lower than at 20 years old (Orentreich et al., 1984). This dramatic age-related decline has led to DHEA being marketed as an "anti-aging" supplement, though its effectiveness for increasing testosterone levels remains controversial.
The Conversion Process
The biosynthesis of active androgens and estrogens from DHEA is achieved by three steroidogenesis-related enzymes. Testosterone is synthesized through metabolism of DHEA by 3β-hydroxysteroid dehydrogenase, known as 3β-HSD, and 17β-HSD enzymes, and in turn, estrogens can be converted from androgens through the enzyme aromatase cytochrome P-450 (Arlt, 2004).
Importantly, this conversion doesn't occur only in the gonads. Recent research demonstrates that skeletal muscles are capable of locally synthesizing circulating DHEA to testosterone and estrogen through these same enzymatic pathways (Aizawa et al., 2007). In target tissues, circulating testosterone is then converted to dihydrotestosterone, or DHT, by the enzyme 5-alpha-reductase and can be aromatized to estradiol by aromatase (Davis et al., 2021).
This peripheral conversion means that testosterone production and its effects are tissue-specific and depend on membrane and cellular receptor expression as well as activity of converting enzymes. Measured serum testosterone concentrations do not necessarily correlate with peripheral tissue androgen production or tissue receptor sensitivity (Davis et al., 2021). This biochemical reality becomes crucial when interpreting laboratory results.
The Lab Test Problem: Why Basic Testosterone Testing Isn't Enough
Walk into most clinics complaining of fatigue, decreased libido, or difficulty building muscle, and you'll likely receive a basic testosterone test. This single blood draw, typically measuring total testosterone, represents a mere snapshot of a dynamic hormonal system. The limitations of this approach create significant problems for accurate diagnosis and appropriate treatment decisions.
Total Testosterone vs. Free Testosterone
Standard laboratory tests typically measure total testosterone, which includes both testosterone bound to proteins and testosterone that circulates freely in the bloodstream. However, only free testosterone, which is the unbound portion, is biologically available to enter cells and exert hormonal effects.
Approximately 98% of testosterone in the bloodstream binds to proteins, primarily sex hormone-binding globulin, or SHBG, and albumin. Only the remaining 2% circulates as free testosterone (Travison et al., 2017). Factors including age, obesity, insulin resistance, thyroid dysfunction, and certain medications can alter SHBG levels, dramatically affecting the ratio of bound to free testosterone.
A man might have total testosterone within the normal reference range but suffer from symptoms of low testosterone because his free testosterone is actually quite low due to elevated SHBG. Conversely, someone with lower total testosterone but low SHBG might have adequate free testosterone and experience no symptoms. This is why comprehensive testing should include not just total testosterone but also free testosterone or calculated bioavailable testosterone.
The Wide and Problematic Reference Ranges
Laboratory reference ranges for testosterone are remarkably broad, typically spanning from 300 to 1,000 nanograms per deciliter for total testosterone. This enormous range means that a man with a level of 320 ng/dL and another at 950 ng/dL are both considered "normal," despite one having three times the testosterone of the other.
Moreover, these reference ranges are population-based, reflecting testosterone levels found in men of various ages. A 25-year-old man with testosterone at 400 ng/dL might be told his levels are "normal," when in fact for his age group, this represents the lower end of expected values. The Massachusetts Male Aging Study reported an annual decline in total and free testosterone of 0.8 to 1.6% and 1.7 to 2.8%, respectively (Feldman et al., 2002). This means optimal testosterone for a 25-year-old looks very different from optimal testosterone for a 65-year-old, yet both are often judged against the same reference range.
Morning vs. Afternoon: Timing Matters
Testosterone levels follow a circadian rhythm, peaking in the early morning hours and declining throughout the day. Testosterone can be approximately 30% lower in the evening compared to morning levels. For accurate assessment, testosterone should be measured between 7 AM and 10 AM when levels are at their peak (Bhasin et al., 2018). A test performed at 3 PM might show "low" testosterone that's actually within normal range when corrected for time of day.
The Critical Importance of Longitudinal Data
Perhaps the most significant limitation of single testosterone measurements is the lack of context. Was your testosterone always 450 ng/dL, or has it dropped from 850 ng/dL over the past several years? The trajectory matters more than the absolute number.
Year-over-year laboratory data provides invaluable information about your hormonal trend. A steady decline might indicate an underlying problem requiring investigation such as pituitary dysfunction, testicular disease, or metabolic disorder. Without historical data, clinicians must guess whether current levels represent your baseline or a significant change. This is why men concerned about testosterone should consider establishing a baseline with comprehensive testing in their late 20s or early 30s and retesting every few years to track changes over time.
The Consequences of Testosterone Supplementation
Testosterone replacement therapy, when appropriately prescribed and carefully monitored, can dramatically improve quality of life for men with confirmed hypogonadism. However, introducing exogenous testosterone creates a cascade of physiological changes, some beneficial, some neutral, and some potentially problematic. Understanding these consequences is essential for informed decision-making.
“For most men, declining testosterone is not a health issue. But it’s made into a health issue when they are told there is a replacement and that private doctors are willing to prescribe it to them.”
Source: Men's Health UK – Testosterone Myths & Misconceptions
Suppression of Natural Production
One of the most significant and often underemphasized consequences of TRT is suppression of the body's natural testosterone production through negative feedback on the hypothalamic-pituitary-gonadal axis, also known as the HPG axis. When synthetic testosterone enters the bloodstream, the hypothalamus and pituitary gland detect elevated hormone levels and respond by reducing or completely shutting down the signals that tell the testes to produce testosterone and sperm.
This suppression can become complete and, in some cases, may not fully reverse even after discontinuing TRT. For men hoping to maintain fertility, this represents a critical concern. Testosterone replacement therapy should be considered potentially sterilizing, as sperm production often declines significantly or ceases entirely during treatment (Crosnoe et al., 2013).
Cardiovascular Considerations
The cardiovascular effects of testosterone replacement therapy have been subject to intense scrutiny and debate. While earlier observational studies suggested increased risks of heart attacks and strokes, the landmark TRAVERSE trial, a large multicenter randomized controlled trial published in 2023, provided more reassuring data.
The TRAVERSE trial enrolled 5,246 men aged 45 to 80 years who had preexisting or high risk of cardiovascular disease and confirmed hypogonadism. The study found that testosterone replacement therapy was non-inferior to placebo for cardiovascular safety, meaning it did not significantly increase the risk of cardiovascular events (Lincoff et al., 2023). However, men on TRT should still be monitored for cardiovascular risk factors including blood pressure and lipid profiles, as individual responses vary.
Erythrocytosis: The Blood Thickening Effect
One of the most common and clinically significant side effects of testosterone replacement is erythrocytosis, which means an increase in red blood cell mass. Testosterone stimulates erythropoiesis, the production of red blood cells, leading to elevated hematocrit levels.
While increased oxygen-carrying capacity might sound beneficial, excessively high hematocrit significantly increases blood viscosity, or thickness, creating elevated risk for blood clots, deep vein thrombosis, pulmonary embolism, and stroke. Studies show that hematocrit increases significantly with TRT irrespective of the formulation used, with intramuscular testosterone causing the most significant increase of approximately 4% (Kohn et al., 2016).
Men on testosterone replacement require regular monitoring of hematocrit levels, typically every three to six months initially and then biannually once stable. If hematocrit exceeds 52%, therapeutic phlebotomy, which is essentially controlled blood donation, becomes necessary to reduce blood volume and prevent thrombotic complications.
Prostate Health Monitoring
The relationship between testosterone and prostate health has long been controversial. Historically, concerns about testosterone "feeding" prostate cancer led to extreme caution about TRT. Contemporary evidence suggests a more nuanced picture.
Current research indicates that testosterone replacement therapy in men with confirmed hypogonadism does not appear to increase the risk of developing new prostate cancer (Cui et al., 2014). However, TRT remains absolutely contraindicated in men with existing, untreated prostate cancer, as testosterone can stimulate growth of existing cancer cells.
Men considering or using TRT should undergo baseline prostate-specific antigen, or PSA, testing and digital rectal examination, with continued monitoring during treatment. Unexplained PSA elevation warrants immediate urological evaluation.
Effects on Mood and Behavior
Testosterone influences mood, cognition, and behavior through complex mechanisms in the central nervous system. While many men report improved mood, energy, and sense of wellbeing on TRT, others experience increased irritability, aggression, or mood swings, particularly if testosterone levels fluctuate significantly between doses.
Injectable testosterone formulations that create peaks and troughs in serum levels can produce corresponding mood fluctuations. Transdermal applications that provide more stable hormone levels may minimize these effects for susceptible individuals.
DHT and Male Pattern Baldness: An Accelerated Timeline
For men with genetic susceptibility to male pattern baldness, also known as androgenetic alopecia, testosterone replacement therapy can significantly accelerate hair loss through the conversion of testosterone to dihydrotestosterone.
The DHT Mechanism
Dihydrotestosterone, abbreviated as DHT, is a more potent androgen than testosterone, binding to androgen receptors with greater affinity and remaining bound for longer periods. DHT is formed from testosterone through the action of the enzyme 5-alpha-reductase, which exists in two isoforms. Type 1 5-alpha-reductase is found mainly in sebaceous glands and the epidermis, while type 2 is predominantly located in hair follicles and the prostate.
In hair follicles that are genetically susceptible, DHT binds to androgen receptors and, through mechanisms that are not completely understood, triggers follicular miniaturization. This is a biological process where hair follicles progressively shrink with each growth cycle. The growth phase, called anagen, becomes shorter, while the resting phase, known as telogen, lengthens. Eventually, follicles produce only thin, short, barely visible hairs before ceasing production entirely.
Importantly, increased DHT levels in balding scalp compared with non-balding scalp have been documented, challenging the notion that hair loss is purely about receptor sensitivity to normal DHT levels (Sawaya & Price, 1997). The actual amount of androgen differs between affected and unaffected areas.
Genetic Susceptibility
Male pattern baldness follows a complex polygenic inheritance pattern. While the androgen receptor gene located on the X chromosome plays a significant role, recent genetic studies have identified 63 genes that may contribute to male pattern baldness, with only six found on the X chromosome (Hagenaars et al., 2017). This means that the old myth about inheriting baldness solely from your mother's father is oversimplified. However, if male pattern baldness runs in your family particularly on both sides, you have significantly increased risk.
Testosterone Supplementation Accelerates the Process
For men with genetic susceptibility to male pattern baldness, increasing testosterone levels through TRT provides more substrate for conversion to DHT. This doesn't cause hair loss in men without genetic predisposition, but it can dramatically accelerate the timeline for those who are genetically susceptible.
A man who might have maintained a reasonably full head of hair until his 50s or 60s might experience significant recession and thinning in his 30s or 40s when using testosterone supplementation. The effect is dose-dependent: higher testosterone levels mean more DHT production and faster hair loss in susceptible individuals.
Some men on TRT use 5-alpha-reductase inhibitors such as finasteride or dutasteride to block the conversion of testosterone to DHT, potentially slowing hair loss. However, these medications come with their own side effects, including potential sexual dysfunction and, paradoxically, can interfere with some of the benefits men seek from TRT.
Making an Informed Decision
Men with noticeable family history of male pattern baldness should carefully weigh the cosmetic implications of TRT against its benefits. While hair loss may seem superficial compared to other health considerations, its psychological impact can be significant. An honest conversation with your physician about your genetic risk and the realistic timeline for hair loss should be part of the informed consent process before starting testosterone therapy.
Questions to Ask Your Physician
The decision to begin testosterone replacement therapy should never be made lightly or based solely on marketing promises or a single laboratory value. Before starting TRT, men should have comprehensive discussions with their healthcare providers, ideally a urologist or endocrinologist with expertise in male hormone health. Essential questions include:
What are my free testosterone and SHBG levels, not just total testosterone?
Understanding the complete hormonal picture prevents treating men who don't actually have biologically low testosterone despite borderline total testosterone levels.
Do I have year-over-year data showing a declining trend?
A single low measurement might represent normal variation, stress, illness, or testing at the wrong time of day rather than true hypogonadism.
Have we investigated potential underlying causes of low testosterone?
Conditions including sleep apnea, obesity, metabolic syndrome, pituitary disorders, testicular disease, and certain medications can all cause low testosterone. Addressing these root causes might restore normal levels without requiring lifelong hormone replacement.
What are my treatment options, and how do they differ?
Testosterone replacement comes in multiple formulations including injections, transdermal gels, patches, pellets, and oral medications. Each has different pharmacokinetics, convenience profiles, side effect patterns, and costs.
What monitoring will be required, and how often?
Appropriate TRT management requires regular testing of testosterone levels, hematocrit, PSA, liver function, and cardiovascular markers. Understanding this commitment before starting ensures realistic expectations.
Am I concerned about fertility now or in the future?
Men hoping to father children should explore alternatives to traditional TRT, such as clomiphene citrate or human chorionic gonadotropin, which stimulate natural testosterone production without suppressing sperm production.
Given my family history, what is my risk for accelerated hair loss?
Honest discussion about genetic susceptibility to male pattern baldness and the likely timeline for hair loss on TRT allows for informed decision-making.
What happens if I want to stop TRT later?
Understanding that discontinuing testosterone after long-term use can be challenging, with potential for prolonged hypogonadal symptoms while the body attempts to restart natural production, is crucial for informed consent.
Are there alternative approaches we should try first?
Lifestyle modifications including weight loss, improved sleep, stress reduction, resistance training, and optimized nutrition can significantly improve testosterone levels in many men without pharmaceutical intervention.
Acupuncture and Natural Hormone Balance Through Cortisol Regulation
While testosterone replacement therapy may be necessary for some men with confirmed hypogonadism, supporting the body's natural hormone production offers an appealing complementary or alternative approach. Acupuncture, rooted in Traditional Chinese Medicine, influences hormonal balance through multiple mechanisms, particularly through regulation of the stress hormone cortisol and modulation of the hypothalamic-pituitary-gonadal axis.
The Cortisol-Testosterone Connection
Cortisol, the primary stress hormone produced by the adrenal glands, exerts profound effects on the entire endocrine system. Chronic stress and persistently elevated cortisol levels suppress testosterone production through multiple pathways. Elevated cortisol reduces the pituitary gland's response to gonadotropin-releasing hormone, subsequently decreasing production of luteinizing hormone and follicle-stimulating hormone, which are the signals that tell the testes to produce testosterone and sperm.
Additionally, cortisol and testosterone share biochemical precursors in the steroid synthesis pathway. When the body prioritizes cortisol production in response to chronic stress, less DHEA becomes available for conversion to testosterone. This phenomenon, sometimes called "cortisol steal," can significantly depress testosterone levels in chronically stressed men.
How Acupuncture Regulates Cortisol
Research demonstrates that acupuncture influences the hypothalamic-pituitary-adrenal axis, which governs cortisol production and stress responses. While individual study results vary, a body of evidence suggests acupuncture can help normalize cortisol levels, particularly in people with dysregulated stress responses.
Studies using animal models have shown that acupuncture reverses testosterone and corticosterone disturbances caused by chronic stress. In one study, rats subjected to social isolation stress exhibited decreased testosterone and elevated corticosterone levels, along with depression-like behaviors. Acupuncture treatment normalized both hormone levels and behavior, suggesting that acupuncture's antidepressant effects may be related to improvement of hormonal disturbances associated with chronic stress (Rojas-Durán et al., 2021).
Research on acupuncture for depression indicates that treatment can modulate levels of cortisol, testosterone, and estradiol in patients with stress-related hormonal imbalances (Huang et al., 1997). By calming the nervous system and promoting parasympathetic dominance, the body's rest and restoration mode, acupuncture helps reduce chronically elevated cortisol that suppresses testosterone production.
Supporting the HPG Axis
Beyond cortisol regulation, acupuncture appears to influence the hypothalamic-pituitary-gonadal axis directly. Research suggests that acupuncture may increase luteinizing hormone release from the pituitary gland, which directly stimulates testosterone production in the testes. Additionally, acupuncture enhances blood flow to the testes while reducing oxidative stress that damages Leydig cells, which are the cells responsible for testosterone synthesis.
Acupuncture also improves other factors that influence testosterone levels including insulin sensitivity, sleep quality, and metabolic function. By addressing these interconnected systems, acupuncture creates conditions that support optimal natural hormone production rather than simply adding synthetic hormones.
A Complementary Approach
For men with mild testosterone deficiency or those who prefer to avoid or delay pharmaceutical intervention, acupuncture combined with lifestyle optimization offers a viable approach. Even for men already on TRT, acupuncture can help manage side effects, support cardiovascular health, reduce stress, and promote overall wellbeing.
Supporting Hormone Health at Golden Mean Acupuncture
At Golden Mean Acupuncture in Los Angeles, a comprehensive approach to men's hormone health recognizes that testosterone levels don't exist in isolation but rather reflect the overall balance of the endocrine, nervous, and metabolic systems. Through personalized acupuncture treatments, practitioners address the root causes of hormonal imbalance including chronic stress, poor sleep, metabolic dysfunction, and HPA axis dysregulation.
Treatment protocols focus on regulating cortisol levels, supporting healthy sleep patterns, improving circulation to reproductive organs, and rebalancing the autonomic nervous system to shift from sympathetic dominance toward parasympathetic activity. This creates optimal conditions for natural testosterone production and helps the body maintain hormonal equilibrium.
For men already using testosterone replacement therapy, acupuncture serves as valuable adjunctive care, helping manage side effects including anxiety, sleep disturbances, and cardiovascular concerns while supporting overall vitality and wellbeing. The practice works collaboratively with patients' existing healthcare teams, providing complementary support that enhances rather than replaces conventional medical care.
Located in historic Angelino Heights near Dodger Stadium, Golden Mean Acupuncture serves the Los Angeles communities of Echo Park, Silver Lake, Los Feliz, Koreatown, Downtown LA, and East Hollywood. Whether exploring natural approaches to hormone optimization or seeking support during testosterone replacement therapy, the clinic offers evidence-informed care that honors both ancient healing wisdom and contemporary medical understanding.
FAQ:
-
While symptoms like fatigue, low libido, and difficulty building muscle suggest low testosterone, they're nonspecific and can result from many other conditions including depression, sleep disorders, thyroid problems, or simply aging. Confirmation requires comprehensive laboratory testing, not just symptom assessment.
-
Not necessarily, but discontinuing after long-term use can be challenging. The body's natural testosterone production may remain suppressed for months after stopping, and some men never fully recover their baseline levels. This possibility should be considered before starting.
-
TRT can improve body composition by increasing lean muscle mass and potentially reducing fat mass, but it's not a weight loss treatment. The most dramatic benefits occur in men who combine TRT with resistance training and proper nutrition. Testosterone alone without lifestyle changes produces modest results at best.
-
Sexual function improvements often appear within 3-6 weeks. Energy, mood, and quality of life benefits typically manifest within 3-6 months. Changes in body composition, muscle mass, and bone density require 6-12 months or longer.
References
Aizawa, K., Iemitsu, M., Maeda, S., Jesmin, S., Otsuki, T., Mowa, C. N., Miyauchi, T., & Mesaki, N. (2007). Expression of steroidogenic enzymes and synthesis of sex steroid hormones from DHEA in skeletal muscle of rats. *American Journal of Physiology-Endocrinology and Metabolism*, 292(2), E577-E584.
Arlt, W. (2004). Dehydroepiandrosterone replacement therapy. *Seminars in Reproductive Medicine*, 22(4), 379-388.
Baillargeon, J., Urban, R. J., Ottenbacher, K. J., Pierson, K. S., & Goodwin, J. S. (2013). Trends in androgen prescribing in the United States, 2001 to 2011. *JAMA Internal Medicine*, 173(15), 1465-1466.
Bhasin, S., Brito, J. P., Cunningham, G. R., Hayes, F. J., Hodis, H. N., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., Wu, F. C., & Yialamas, M. A. (2018). Testosterone therapy in men with hypogonadism: An Endocrine Society clinical practice guideline. *Journal of Clinical Endocrinology & Metabolism*, 103(5), 1715-1744.
Crosnoe, L. E., Grober, E., Ohl, D., & Kim, E. D. (2013). Exogenous testosterone: A preventable cause of male infertility. *Translational Andrology and Urology*, 2(2), 106-113.
Cui, Y., Zong, H., Yan, H., Li, N., & Zhang, Y. (2014). The effect of testosterone replacement therapy on prostate cancer: A systematic review and meta-analysis. *Prostate Cancer and Prostatic Diseases*, 17(2), 132-143.
Davis, S. R., Baber, R., Panay, N., Bitzer, J., Perez, S. C., Islam, R. M., Kaunitz, A. M., Kingsberg, S. A., Lambrinoudaki, I., Liu, J., Parish, S. J., Pinkerton, J., Rymer, J., Simon, J. A., Vignozzi, L., & Wierman, M. E. (2021). Prescribing testosterone and DHEA: The role of androgens in women. *Cleveland Clinic Journal of Medicine*, 88(1), 35-43.
Feldman, H. A., Longcope, C., Derby, C. A., Johannes, C. B., Araujo, A. B., Coviello, A. D., Bremner, W. J., & McKinlay, J. B. (2002). Age trends in the level of serum testosterone and other hormones in middle-aged men: Longitudinal results from the Massachusetts male aging study. *Journal of Clinical Endocrinology & Metabolism*, 87(2), 589-598.
Hagenaars, S. P., Hill, W. D., Harris, S. E., Ritchie, S. J., Davies, G., Liewald, D. C., Gale, C. R., Porteous, D. J., Deary, I. J., & Marioni, R. E. (2017). Genetic prediction of male pattern baldness. *PLOS Genetics*, 13(2), e1006594.
Hornsby, P. J. (1995). Biosynthesis of DHEAS by the human adrenal cortex and its age-related decline. *Annals of the New York Academy of Sciences*, 774, 29-46.
Huang, D. M., Chen, X. Y., & Huang, P. Q. (1997). Effects of different acupuncture manipulation on plasma estradiol, testosterone and cortisol in patients with kidney deficiency. *Zhongguo Zhen Jiu*, 17(12), 721-723.
Kohn, T. P., Louis, M. R., Pickett, S. M., Lindgren, M. C., Kohn, J. R., Pastuszak, A. W., & Lipshultz, L. I. (2016). Age and duration of testosterone therapy predict time to return of sperm count after human chorionic gonadotropin therapy. *Fertility and Sterility*, 106(6), 1415-1421.
Lincoff, A. M., Bhasin, S., Flevaris, P., Mitchell, L. M., Basaria, S., Boden, W. E., Cunningham, G. R., Granger, C. B., Khera, M., Thompson, I. M., Wang, Q., Wolski, K., Davey, D., Kalahasti, V., Khan, N., Miller, M. G., Snabes, M. C., Chan, A., Dubcenco, E., ... & Nissen, S. E. (2023). Cardiovascular safety of testosterone replacement therapy. *New England Journal of Medicine*, 389(2), 107-117.
Orentreich, N., Brind, J. L., Rizer, R. L., & Vogelman, J. H. (1984). Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. *Journal of Clinical Endocrinology & Metabolism*, 59(3), 551-555.
Rojas-Durán, F., Medina, Y. I., Panamá-Matos, R., Arenas, M. C., & Torner, L. (2021). Antidepressant-like effects of acupuncture via modulation of corticosterone, sex hormones, and hippocampal BDNF expression in male rats. *Neuroscience Letters*, 745, 135622.
Sawaya, M. E., & Price, V. H. (1997). Different levels of 5α-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. *Journal of Investigative Dermatology*, 109(3), 296-300.
Travison, T. G., Vesper, H. W., Orwoll, E., Wu, F., Kaufman, J. M., Wang, Y., Lapauw, B., Fiers, T., Matsumoto, A. M., & Bhasin, S. (2017). Harmonized reference ranges for circulating testosterone levels in men of four cohort studies in the United States and Europe. *Journal of Clinical Endocrinology & Metabolism*, 102(4), 1161-1173.